In humans, defective Polη has clinical implications: Polη is the product of the gene mutated in Xeroderma Pigmentosum complementation group “Variant” (XPV), a syndrome that is associated with a high predisposition towards developing skin cancers [10]. Here, POLH is linked to skin cancer.